ArticleCancer medicine2023

The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC-GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis.

Takeshi Hatanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.